1. Home
  2. RMD vs LVS Comparison

RMD vs LVS Comparison

Compare RMD & LVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMD
  • LVS
  • Stock Information
  • Founded
  • RMD 1989
  • LVS 1988
  • Country
  • RMD United States
  • LVS United States
  • Employees
  • RMD N/A
  • LVS N/A
  • Industry
  • RMD Medical/Dental Instruments
  • LVS Hotels/Resorts
  • Sector
  • RMD Health Care
  • LVS Consumer Discretionary
  • Exchange
  • RMD Nasdaq
  • LVS Nasdaq
  • Market Cap
  • RMD 31.8B
  • LVS 27.1B
  • IPO Year
  • RMD 1995
  • LVS 2004
  • Fundamental
  • Price
  • RMD $244.62
  • LVS $41.14
  • Analyst Decision
  • RMD Buy
  • LVS Buy
  • Analyst Count
  • RMD 13
  • LVS 13
  • Target Price
  • RMD $259.40
  • LVS $56.83
  • AVG Volume (30 Days)
  • RMD 916.1K
  • LVS 6.2M
  • Earning Date
  • RMD 04-23-2025
  • LVS 07-23-2025
  • Dividend Yield
  • RMD 0.87%
  • LVS 2.43%
  • EPS Growth
  • RMD 37.08
  • LVS N/A
  • EPS
  • RMD 8.91
  • LVS 1.78
  • Revenue
  • RMD $5,021,529,000.00
  • LVS $11,201,000,000.00
  • Revenue This Year
  • RMD $10.37
  • LVS $5.21
  • Revenue Next Year
  • RMD $7.77
  • LVS $5.92
  • P/E Ratio
  • RMD $27.47
  • LVS $23.07
  • Revenue Growth
  • RMD 9.54
  • LVS N/A
  • 52 Week Low
  • RMD $179.42
  • LVS $30.18
  • 52 Week High
  • RMD $263.05
  • LVS $56.61
  • Technical
  • Relative Strength Index (RSI)
  • RMD 56.30
  • LVS 57.41
  • Support Level
  • RMD $242.22
  • LVS $39.29
  • Resistance Level
  • RMD $247.48
  • LVS $42.17
  • Average True Range (ATR)
  • RMD 3.86
  • LVS 0.96
  • MACD
  • RMD -1.26
  • LVS -0.11
  • Stochastic Oscillator
  • RMD 21.98
  • LVS 55.89

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About LVS Las Vegas Sands Corp.

Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.

Share on Social Networks: